Loading…
Pharmacologic treatment of fibromyalgia
Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management s...
Saved in:
Published in: | Current psychiatry reports 2006-11, Vol.8 (6), p.464-469 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43 |
container_end_page | 469 |
container_issue | 6 |
container_start_page | 464 |
container_title | Current psychiatry reports |
container_volume | 8 |
creator | Baker, Kathryn Barkhuizen, Andre |
description | Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia. |
doi_str_mv | 10.1007/s11920-006-0052-9 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2406909495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2406909495</sourcerecordid><originalsourceid>FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43</originalsourceid><addsrcrecordid>eNotkDtPAzEQhC0EEiHwA-hOoqAy7Pp1cYkiXlIkKKC29hw7XJSLg30p8u-501GMZorR7Opj7BbhAQHqx4JoBXAAM0gLbs_YDLXUHI3S52MWkssFikt2VcoWQAAsxIzdf_5Q7sinXdq0vupzoL4L-75KsYptk1N3ot2mpWt2EWlXws2_z9n3y_PX8o2vPl7fl08r7tHonjemVsGilaKJWEMQJmAU1EBjFC1qRRTqNUZlfBBkhse1WZvorSRPtSUl5-xu2j3k9HsMpXfbdMz74aQTCowFq6weWji1fE6l5BDdIbcd5ZNDcCMPN_FwAw838nBW_gFfDlH0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2406909495</pqid></control><display><type>article</type><title>Pharmacologic treatment of fibromyalgia</title><source>Springer Nature</source><creator>Baker, Kathryn ; Barkhuizen, Andre</creator><creatorcontrib>Baker, Kathryn ; Barkhuizen, Andre</creatorcontrib><description>Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.</description><identifier>ISSN: 1523-3812</identifier><identifier>EISSN: 1535-1645</identifier><identifier>DOI: 10.1007/s11920-006-0052-9</identifier><language>eng</language><publisher>New York: Springer Nature B.V</publisher><subject>Fibromyalgia ; Psychiatry</subject><ispartof>Current psychiatry reports, 2006-11, Vol.8 (6), p.464-469</ispartof><rights>Current Science Inc 2006.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Baker, Kathryn</creatorcontrib><creatorcontrib>Barkhuizen, Andre</creatorcontrib><title>Pharmacologic treatment of fibromyalgia</title><title>Current psychiatry reports</title><description>Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.</description><subject>Fibromyalgia</subject><subject>Psychiatry</subject><issn>1523-3812</issn><issn>1535-1645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNotkDtPAzEQhC0EEiHwA-hOoqAy7Pp1cYkiXlIkKKC29hw7XJSLg30p8u-501GMZorR7Opj7BbhAQHqx4JoBXAAM0gLbs_YDLXUHI3S52MWkssFikt2VcoWQAAsxIzdf_5Q7sinXdq0vupzoL4L-75KsYptk1N3ot2mpWt2EWlXws2_z9n3y_PX8o2vPl7fl08r7tHonjemVsGilaKJWEMQJmAU1EBjFC1qRRTqNUZlfBBkhse1WZvorSRPtSUl5-xu2j3k9HsMpXfbdMz74aQTCowFq6weWji1fE6l5BDdIbcd5ZNDcCMPN_FwAw838nBW_gFfDlH0</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Baker, Kathryn</creator><creator>Barkhuizen, Andre</creator><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20061101</creationdate><title>Pharmacologic treatment of fibromyalgia</title><author>Baker, Kathryn ; Barkhuizen, Andre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Fibromyalgia</topic><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baker, Kathryn</creatorcontrib><creatorcontrib>Barkhuizen, Andre</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Current psychiatry reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baker, Kathryn</au><au>Barkhuizen, Andre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacologic treatment of fibromyalgia</atitle><jtitle>Current psychiatry reports</jtitle><date>2006-11-01</date><risdate>2006</risdate><volume>8</volume><issue>6</issue><spage>464</spage><epage>469</epage><pages>464-469</pages><issn>1523-3812</issn><eissn>1535-1645</eissn><abstract>Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating a successful pharmacologic treatment program for patients with fibromyalgia.</abstract><cop>New York</cop><pub>Springer Nature B.V</pub><doi>10.1007/s11920-006-0052-9</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1523-3812 |
ispartof | Current psychiatry reports, 2006-11, Vol.8 (6), p.464-469 |
issn | 1523-3812 1535-1645 |
language | eng |
recordid | cdi_proquest_journals_2406909495 |
source | Springer Nature |
subjects | Fibromyalgia Psychiatry |
title | Pharmacologic treatment of fibromyalgia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A54%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacologic%20treatment%20of%20fibromyalgia&rft.jtitle=Current%20psychiatry%20reports&rft.au=Baker,%20Kathryn&rft.date=2006-11-01&rft.volume=8&rft.issue=6&rft.spage=464&rft.epage=469&rft.pages=464-469&rft.issn=1523-3812&rft.eissn=1535-1645&rft_id=info:doi/10.1007/s11920-006-0052-9&rft_dat=%3Cproquest_cross%3E2406909495%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c165t-b674e91932bf170e26e1f2ab0b64a874aae7d1f46ce2a600756d6fc93aca79a43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2406909495&rft_id=info:pmid/&rfr_iscdi=true |